E. Uno

发表

Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.

Y. Okita, Y. Hirami, Y. Kurimoto, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Phase II Clinical Trial of CD 34 + Cell Therapy to Explore Endpoint Selection and Timing in Patients With Critical Limb Ischemia

Y. Okita, Y. Hirami, Y. Kurimoto, 2014 .